The Agence Marocaine du Médicament et des Produits de Santé (AMMPS) has called on industrial pharmaceutical establishments and wholesaler-distributors to strengthen vigilance and ensure continuity of national supply during the 2026-2027 winter period.
The authority issued the call on 13 November 2026 in anticipation of increased demand for medicines during winter, characterised by a rise in respiratory infections and cold waves. Particular attention should be paid to paediatric populations, with manufacturers and distributors asked to ensure availability of essential medicines in pharmaceutical forms and dosages suitable for infants and children.
Pharmaceutical establishments are invited to anticipate seasonal needs and adapt production, importation and distribution programmes; maintain safety stocks in accordance with current regulations; ensure sufficient availability of essential medicines, particularly those for winter and paediatric conditions; and report without delay any difficulty that could affect supply continuity.
Source: Agence Marocaine du Médicament et des Produits de Santé (AMMPS), Note d’information 13/11/2026, 13 November 2026: https://ammps.gov.ma/note-information/securisation-de-lapprovisionnement-en-medicaments-durant-la-periode-hivernale-2026-2027
